Use of beryllium lymphocyte proliferation testing for screening of asymptomatic individuals: An evidence-based assessment

Jonathan Borak, Steven H. Woolf, Cheryl A. Fields

Research output: Contribution to journalArticle

Abstract

OBJECTIVE: We reviewed published data describing use of beryllium lymphocyte proliferation testing (BeLPT) to determine the appropriateness of BeLPT for screening asymptomatic individuals. METHODS: Published studies were identified by computerized literature searches and hand searches of relevant bibliographies and cited references. Critical assessment of evidence focused on five elements essential to judging effectiveness of preventive services: 1) burden of suffering, 2) accuracy and reliability of screening tests, 3) effectiveness of early detection, 4) harms of screening, and 5) benefits outweighing harms. RESULTS: Important gaps and deficiencies in the evidence were found. The prevalence of beryllium sensitization and chronic beryllium disease in asymptomatic individuals are unknown. The accuracy and reliability of BeLPT are uncertain. Marked intra- and interlaboratory variability has been reported. The clinical benefits of early intervention have not been confirmed or quantified in asymptomatic individuals. CONCLUSIONS: There is currently insufficient scientific evidence to support the use of BeLPT for routine screening of asymptomatic individuals.

Original languageEnglish (US)
Pages (from-to)937-947
Number of pages11
JournalJournal of Occupational and Environmental Medicine
Volume48
Issue number9
DOIs
StatePublished - Sep 2006
Externally publishedYes

Fingerprint

Beryllium
Lymphocytes
Berylliosis
Bibliography
Psychological Stress
Chronic Disease

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Health, Toxicology and Mutagenesis

Cite this

Use of beryllium lymphocyte proliferation testing for screening of asymptomatic individuals : An evidence-based assessment. / Borak, Jonathan; Woolf, Steven H.; Fields, Cheryl A.

In: Journal of Occupational and Environmental Medicine, Vol. 48, No. 9, 09.2006, p. 937-947.

Research output: Contribution to journalArticle

@article{974163bbe40840e6a4e816f4399cdc84,
title = "Use of beryllium lymphocyte proliferation testing for screening of asymptomatic individuals: An evidence-based assessment",
abstract = "OBJECTIVE: We reviewed published data describing use of beryllium lymphocyte proliferation testing (BeLPT) to determine the appropriateness of BeLPT for screening asymptomatic individuals. METHODS: Published studies were identified by computerized literature searches and hand searches of relevant bibliographies and cited references. Critical assessment of evidence focused on five elements essential to judging effectiveness of preventive services: 1) burden of suffering, 2) accuracy and reliability of screening tests, 3) effectiveness of early detection, 4) harms of screening, and 5) benefits outweighing harms. RESULTS: Important gaps and deficiencies in the evidence were found. The prevalence of beryllium sensitization and chronic beryllium disease in asymptomatic individuals are unknown. The accuracy and reliability of BeLPT are uncertain. Marked intra- and interlaboratory variability has been reported. The clinical benefits of early intervention have not been confirmed or quantified in asymptomatic individuals. CONCLUSIONS: There is currently insufficient scientific evidence to support the use of BeLPT for routine screening of asymptomatic individuals.",
author = "Jonathan Borak and Woolf, {Steven H.} and Fields, {Cheryl A.}",
year = "2006",
month = "9",
doi = "10.1097/01.jom.0000232548.03207.9f",
language = "English (US)",
volume = "48",
pages = "937--947",
journal = "Journal of Occupational and Environmental Medicine",
issn = "1076-2752",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - Use of beryllium lymphocyte proliferation testing for screening of asymptomatic individuals

T2 - An evidence-based assessment

AU - Borak, Jonathan

AU - Woolf, Steven H.

AU - Fields, Cheryl A.

PY - 2006/9

Y1 - 2006/9

N2 - OBJECTIVE: We reviewed published data describing use of beryllium lymphocyte proliferation testing (BeLPT) to determine the appropriateness of BeLPT for screening asymptomatic individuals. METHODS: Published studies were identified by computerized literature searches and hand searches of relevant bibliographies and cited references. Critical assessment of evidence focused on five elements essential to judging effectiveness of preventive services: 1) burden of suffering, 2) accuracy and reliability of screening tests, 3) effectiveness of early detection, 4) harms of screening, and 5) benefits outweighing harms. RESULTS: Important gaps and deficiencies in the evidence were found. The prevalence of beryllium sensitization and chronic beryllium disease in asymptomatic individuals are unknown. The accuracy and reliability of BeLPT are uncertain. Marked intra- and interlaboratory variability has been reported. The clinical benefits of early intervention have not been confirmed or quantified in asymptomatic individuals. CONCLUSIONS: There is currently insufficient scientific evidence to support the use of BeLPT for routine screening of asymptomatic individuals.

AB - OBJECTIVE: We reviewed published data describing use of beryllium lymphocyte proliferation testing (BeLPT) to determine the appropriateness of BeLPT for screening asymptomatic individuals. METHODS: Published studies were identified by computerized literature searches and hand searches of relevant bibliographies and cited references. Critical assessment of evidence focused on five elements essential to judging effectiveness of preventive services: 1) burden of suffering, 2) accuracy and reliability of screening tests, 3) effectiveness of early detection, 4) harms of screening, and 5) benefits outweighing harms. RESULTS: Important gaps and deficiencies in the evidence were found. The prevalence of beryllium sensitization and chronic beryllium disease in asymptomatic individuals are unknown. The accuracy and reliability of BeLPT are uncertain. Marked intra- and interlaboratory variability has been reported. The clinical benefits of early intervention have not been confirmed or quantified in asymptomatic individuals. CONCLUSIONS: There is currently insufficient scientific evidence to support the use of BeLPT for routine screening of asymptomatic individuals.

UR - http://www.scopus.com/inward/record.url?scp=33748691187&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748691187&partnerID=8YFLogxK

U2 - 10.1097/01.jom.0000232548.03207.9f

DO - 10.1097/01.jom.0000232548.03207.9f

M3 - Article

C2 - 16966961

AN - SCOPUS:33748691187

VL - 48

SP - 937

EP - 947

JO - Journal of Occupational and Environmental Medicine

JF - Journal of Occupational and Environmental Medicine

SN - 1076-2752

IS - 9

ER -